QQ客服 官方微博 反馈留言

	The abnormal function of CD39(+) regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia
	Zhan, Yanxia; Liu, Chanjuan; Ke, Yang; Min, Zhihui; Sun, Lihua; Chen, Hao; Cheng, Yunfeng; Lu, Yumeng; Cheng, Luya; Li, Feng
刊名	ANNALS OF HEMATOLOGY
	2019
卷号	98期号:8
关键词	Immune thrombocytopenia Regulatory T cell CD39 Adenosine receptor A2AR Dexamethasone
ISSN号	0939-5555
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3594569
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhan, Yanxia,Liu, Chanjuan,Ke, Yang,et al. The abnormal function of CD39(+) regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia[J]. ANNALS OF HEMATOLOGY,2019,98(8).
APA	Zhan, Yanxia.,Liu, Chanjuan.,Ke, Yang.,Min, Zhihui.,Sun, Lihua.,...&Wu, Boting.(2019).The abnormal function of CD39(+) regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia.ANNALS OF HEMATOLOGY,98(8).
MLA	Zhan, Yanxia,et al."The abnormal function of CD39(+) regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia".ANNALS OF HEMATOLOGY 98.8(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。